1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
653D08A15905E3C4D85256C9300719884
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-winning-trademarks-development-strategies?opendocument
18
19opendocument
203.88.220.93
21
22
23
24/bestp/domrep.nsf
25DB




Products & Services Brand Management and Product Leadership Branding and Identity

Winning Trademark Development Strategies

DB Image

ID: 4391


Features:

Metrics, Graphics, Summary Matrix


Pages/Slides: 29


Published: Pre-2014


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
This document contains tactics to help pharmaceutical companies uncover successful strategies for trademark development. This benchmarking research includes insights and lessons learned from six leading pharmaceutical companies on the following key topics: success drivers, global trademark options, brand protection tactics, modifier strategies, and multiple trademark issues.

Industries Profiled:
Pharmaceutical; Health Care; Medical Device


Companies Profiled:
AstraZeneca; Sanofi-aventis; Eli Lilly; GlaxoSmithKline; Johnson & Johnson; Merck


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.